{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T08:04:51Z","timestamp":1648886691562},"reference-count":11,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revista Cl\u00ednica Espa\u00f1ola"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.rce.2011.05.003","type":"journal-article","created":{"date-parts":[[2011,7,6]],"date-time":"2011-07-06T12:25:07Z","timestamp":1309955107000},"page":"488-489","source":"Crossref","is-referenced-by-count":1,"title":["Hipomagnesemia grave en relaci\u00f3n con omeprazol"],"prefix":"10.1016","volume":"211","author":[{"given":"A.","family":"Guti\u00e9rrez Mac\u00edas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Ibarmia Lahuerta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"\u00c1lvarez De Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Lizarralde Palacios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rce.2011.05.003_bib0005","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/archinternmed.2010.64","article-title":"Failing the acid test: benefits of proton pump inhibitors may not justify the risks for many users","volume":"170","author":"Katz","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.rce.2011.05.003_bib0010","unstructured":"FDA Drug Safety Communication: Low magnesium levels can be associated with long-term use of Proton Pump Inhibitor drugs (PPIs) [consultado 10\/03\/2011]. Disponible en: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm245011.htm"},{"key":"10.1016\/j.rce.2011.05.003_bib0015","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.rce.2011.05.003_bib0020","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1016\/j.rce.2011.01.013","article-title":"Omeprazol e hipomagnesemia","volume":"211","author":"Callejas D\u00edaz","year":"2011","journal-title":"Rev Clin Esp"},{"key":"10.1016\/j.rce.2011.05.003_bib0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2009.358","article-title":"New molecular players facilitating Mg(2+) reabsorption in the distal convoluted tubule","volume":"77","author":"Glaudemans","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/j.rce.2011.05.003_bib0030","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/qjmed\/hcq021","article-title":"Hypomagnesaemia due to proton-pump inhibitor therapy: a clinical case series","volume":"103","author":"Mackay","year":"2010","journal-title":"QJM"},{"key":"10.1016\/j.rce.2011.05.003_bib0035","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1053\/j.ajkd.2009.11.019","article-title":"A case series of proton pump inhibitor-induced hypomagnesemia","volume":"56","author":"Hoorn","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.rce.2011.05.003_bib0040","doi-asserted-by":"crossref","first-page":"755","DOI":"10.7326\/0003-4819-151-10-200911170-00016","article-title":"Hypomagnesemia induced by several proton-pump inhibitors","volume":"151","author":"Broeren","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.rce.2011.05.003_bib0045","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1365-2265.2008.03194.x","article-title":"Severe hypomagnesaemia in long-term users of proton-pump inhibitors","volume":"69","author":"Cundy","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.rce.2011.05.003_bib0050","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.medcli.2009.10.019","article-title":"Hipomagnesemia grave debida a tratamiento prolongado con omeprazol","volume":"136","author":"Gato D\u00edez","year":"2011","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.rce.2011.05.003_bib0055","doi-asserted-by":"crossref","unstructured":"Fern\u00e1ndez-Fern\u00e1ndez FJ, Sesma P, Ca\u00ednzos-Romero T, Ferreira L. Hipomagnesemia asociada a tratamiento con omeprazol y test gen\u00e9tico negativo para mutaci\u00f3n en TRPM6. Med Clin (Barc). 2011;137:188-9. Epub 2010 Nov 2.","DOI":"10.1016\/j.medcli.2010.07.015"}],"container-title":["Revista Cl\u00ednica Espa\u00f1ola"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014256511002979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014256511002979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T15:59:27Z","timestamp":1560355167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014256511002979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":11,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0014256511002979"],"URL":"https:\/\/doi.org\/10.1016\/j.rce.2011.05.003","relation":{},"ISSN":["0014-2565"],"issn-type":[{"value":"0014-2565","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}